Novel Respiratory Disability Score Predicts COPD Exacerbations and Mortality in the SPIROMICS Cohort

Area of Science:

• Pulmonary Medicine
• Respiratory Research
• Clinical Phenotyping

Background:

• Chronic obstructive pulmonary disease (COPD) is often associated with severe breathlessness, reduced exercise capacity, and poor health status.
• However, respiratory disability is not well-characterized as a distinct clinical phenotype within COPD.
• Identifying this phenotype is crucial for understanding disease progression and patient outcomes.

Purpose of the Study:

• To define respiratory disability in COPD using established functional measures.
• To investigate the association between this defined respiratory disability and the risk of COPD exacerbations and mortality.

Main Methods:

• Analysis of baseline data from 2332 participants in the SPIROMICS multi-center observational study.
• Participants included those with severe COPD, mild/moderate COPD, smokers without airflow obstruction, and non-smoking controls.
• Respiratory disability was defined by meeting at least 4 out of 7 criteria, including dyspnea scale, activity, walking distance, and quality of life measures.

Main Results:

• Respiratory disability was identified in 13.5% of participants, with higher prevalence in severe COPD (34.5%).
• Individuals with respiratory disability exhibited greater emphysema and air-trapping on HRCT scans.
• A derived disability score independently predicted future exacerbations and demonstrated a nearly threefold increased mortality risk (HR 2.97).

Conclusions:

• A novel SPIROMICS respiratory disability score in COPD correlates with airflow obstruction, lung destruction, and inflammatory markers.
• This score serves as an independent predictor of exacerbations and mortality, validating disability as a significant COPD phenotype.
• These findings highlight the importance of recognizing respiratory disability for comprehensive COPD management and prognosis.